These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1171343)

  • 21. Etorphine binds to multiple opiate receptors of the caudate nucleus with equal affinity but with different kinetics.
    Tolkovsky AM
    Mol Pharmacol; 1982 Nov; 22(3):648-56. PubMed ID: 6296657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of opiate binding to brainstem slices associated with the development of tolerance to morphine in rats.
    Davis ME; Akera T; Brody TM
    J Pharmacol Exp Ther; 1979 Oct; 211(1):112-9. PubMed ID: 226669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins.
    Lazarus LH; Ling N; Guillemin R
    Proc Natl Acad Sci U S A; 1976 Jun; 73(6):2156-9. PubMed ID: 1064883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphiceptin (NH4-tyr-pro-phe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors.
    Chang KJ; Lillian A; Hazum E; Cuatrecasas P; Chang JK
    Science; 1981 Apr; 212(4490):75-7. PubMed ID: 6259732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the agonist and antagonist properties of narcotic analgesic drugs by their actions on the morphine receptor in the guinea pig ileum.
    Kosterlitz HW; Waterfield AA; Berthoud V
    Adv Biochem Psychopharmacol; 1973; 8(0):319-34. PubMed ID: 4211816
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of in vivo and in vitro parameters of opiate receptor binding in naive and tolerant dependent rodents.
    Höllt V; Dum J; Bläsig J; Schubert P; Herz A
    Life Sci; 1975 Jun; 16(12):1823-8. PubMed ID: 1171344
    [No Abstract]   [Full Text] [Related]  

  • 27. Opiate receptor binding in the pituitary gland.
    Simantov R; Snyder SH
    Brain Res; 1977 Mar; 124(1):178-84. PubMed ID: 191146
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of new compounds for opioid activity (1985).
    Woods JH; Medzihradsky F; Smith CB; Winger GD; Gmerek DE
    NIDA Res Monogr; 1986; 67():453-89. PubMed ID: 3018577
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of morphine on the sensitivity of mouse vas deferens and ileum during chronic morphine treatment and its correlation with analgesic tolerance.
    Ramaswamy S; Padmanabha Pillai N; Ghosh MN
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):39-51. PubMed ID: 7194622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human endorphin: comparison with procine endorphin, enkephalin and normorphine.
    Frederickson RC; Schirmer EW; Grinnan EL; Harrell CE; Hewes CR
    Life Sci; 1976 Oct; 19(8):1181-9. PubMed ID: 186681
    [No Abstract]   [Full Text] [Related]  

  • 31. Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia.
    Audigier Y; Mazarguil H; Gout R; Cros J
    Eur J Pharmacol; 1980 Apr; 63(1):35-46. PubMed ID: 6247160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-morphine anti-idiotypic antibodies. Opiate receptor binding and isolated tissue responses.
    Ng DS; Isom GE
    Biochem Pharmacol; 1985 Aug; 34(16):2853-8. PubMed ID: 2992520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid agonist activity of beta-lipotropin fragments: a possible biological source of morphine-like substances in the pituitary.
    Gráf L; Rónai A; Bajusz S; Csheh G; Székely JI
    FEBS Lett; 1976 Apr; 64(1):181-4. PubMed ID: 1269751
    [No Abstract]   [Full Text] [Related]  

  • 34. Morphine dependence and diabetes. II. Alterations of normorphine potency in the guinea-pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration.
    Shook JE; Kachur JF; Brase DA; Dewey WL
    J Pharmacol Exp Ther; 1986 Jun; 237(3):848-52. PubMed ID: 3712282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dihydromorphine-peptide hybrids have mu receptor antagonistic and delta receptor agonistic activity on the mouse vas deferens and bind with high affinity to opioid receptors in rat brain.
    Smith CB; Medzihradsky F; Woods JH
    NIDA Res Monogr; 1986; 75():189-92. PubMed ID: 2828970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the receptor binding characteristics of opiate agonists interacting with mu- or kappa-receptors.
    Kosterlitz HW; Leslie FM
    Br J Pharmacol; 1978 Dec; 64(4):607-14. PubMed ID: 215262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid activity of pro-enkephalin-derived peptides in mouse vas deferens and guinea pig ileum.
    Sánchez-Blázquez P; Garzón J
    Neurosci Lett; 1985 Nov; 61(3):267-71. PubMed ID: 3001596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved assays for the assessment of kappa- and delta-properties of opioid ligands.
    Ward SJ; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1982 Nov; 85(2):163-70. PubMed ID: 6295778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for morphine and morphine-like alkaloid responses resistant to naloxone blockade in the rat vas deferens.
    Miranda H; Huidobro F; Huidobro-Toro JP
    Life Sci; 1979 Apr; 24(16):1511-18. PubMed ID: 224278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.